DDrare
Disease
Drug
Target Gene/Pathway
問合せ先
EN
63. 特発性血小板減少性紫斑病
Idiopathic thrombocytopenic purpura
Clinical trials
/
Disease details
臨床試験数
:
391
/
薬物数
:
235
- (
DrugBank
:
50
) /
標的遺伝子数
:
49
-
標的パスウェイ数
:
139
Search
2 trials found
10
50
100
ALL
diseases per page:
Showing 1 to 2 of 2 diseases
Filter by
Reset
No.
TrialID
Date_
enrollment
Date_
registration
Public_title
Scientific_title
Condition
Intervention
Primary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
Phase
Countries
1
EUCTR2019-004683-22-DK
(
EUCTR
)
12/07/2022
17/05/2022
Daratumumab as a treatment for adult immune thrombocytopenia
Daratumumab as a treatment for adult immune thrombocytopenia - The DART-study
Immune thrombocytopenia
MedDRA version: 23.0;Level: LLT;Classification code 10021245;Term: Idiopathic thrombocytopenic purpura;System Organ Class: 100000004851;Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
Immune thrombocytopenia
MedDRA version: 23.0;Level: LLT;Classification code 10021245;Term: Idiopathi ...
Trade Name:
Darzalex
Product Name:
Daratumumab
Product Code:
L01FC01
INN or Proposed INN:
DARATUMUMAB
Other descriptive name:
HUMAX-CD38
Trade Name:
Darzalex
Product Name:
Daratumumab
Product Code:
L01FC01
INN or Proposed INN:
DARATUMUMAB
Ot ...
Ostfold Hospital Trust
NULL
Authorised-recruitment may be ongoing or finished
Female: yes
Male: yes
21
Phase 2
Denmark;Norway
2
EUCTR2019-004683-22-NO
(
EUCTR
)
16/10/2020
29/04/2020
Daratumumab as a treatment for adult immune thrombocytopenia
Daratumumab as a treatment for adult immune thrombocytopenia - The DART-study
Immune thrombocytopenia
MedDRA version: 23.0;Level: LLT;Classification code 10021245;Term: Idiopathic thrombocytopenic purpura;System Organ Class: 100000004851;Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
Immune thrombocytopenia
MedDRA version: 23.0;Level: LLT;Classification code 10021245;Term: Idiopathi ...
Product Name:
daratumumab
INN or Proposed INN:
DARATUMUMAB
Other descriptive name:
HUMAX-CD38
Ostfold Hospital Trust
NULL
Authorised-recruitment may be ongoing or finished
Female: yes
Male: yes
20
Phase 2
Norway